Skip to content
Politically.com Search all
Menu

Congressional Research Service IF10494

Risk Evaluation and Mitigation Strategies (REMS) and Generic Drugs

Source-supplied metadata for version 2, published Oct 31, 2016.

Source: Congress.govUpdated 2026-08-03 08:12:26 UTC.

Source-supplied fields

Report metadata

Identifier
IF10494
Version
2
Product type
Resources
Status
Archived
Published
Oct 31, 2016
Source updated
Jun 20, 2025, 9:27 pm UTC

Politically.com intentionally does not reproduce the report summary or full text. Use the official Congress.gov links above to read the product in its source context.

Structured Congress.gov references

Related federal bills

No structured bill reference is present in the hydrated Congress.gov metadata cache.